Browsing by Subject "disparities"
Now showing 1 - 4 of 4
- Results Per Page
- Sort Options
Item A Study of Disparities in the Receipt of Anti-Retroviral Drugs, Health Status, and Insurance Coverage Among a Sample of HIV-Positive Adults(2006-12-01) Wittenmyer, Brian F.; Kristine Lykens; Jeffrey Talbert; Tim StrawdermanWittenmyer, Brian F., A Study of Disparities in the Receipt of Anti-Retroviral Drugs, Health Status, and Insurance Coverage among a Sample of HIV-Positive Adults. Master of Public Health (Health Management and Policy), December 2006, 88 pp., 8 tables, references, 32 titles. Anti-retroviral medications (ARV) are effective at treating HIV/AIDS. Medicare, Medicaid, and ADAP are public programs that supply ARVs to needy patients in the U.S. Studies have documented dispartities in AIDS incidence/prevalence, insurance, and ARV-use. The study described demographic, clinical, and insurance characteristics of a sample of HIV+ persons. The study explored relationships between AIDS diagnosis, health status, and ARV-receipt and demographic, insurance, and clinical variables. Disparities in ARV-receipt, AIDS diagnosis, and health-status were found for gender, age, race, geographic region, and SES. Policy recommendations included: shortening the disability waiting-period for Medicare-eligibility, and relaxing Medicaid’s income-eligibility requirements.Item Autism Spectrum Disorder with and Without Co-Occurring Attention Deficit Hyperactivity Disorder: An Analysis of Pathways to Diagnosis and Intervention in a National Sample(2018-05) Thomi, Morgan S.; Mathew, Stephen O.; Miller, Haylie L.; Patterson, Rita M.; Lovely, Rehana S.Autism Spectrum Disorder (ASD) is diagnosed in 1 out of 68 children. Recent changes to diagnostic guidelines permit clinicians to assign co-occurring diagnoses of ASD and Attention Deficit-Hyperactivity Disorder (ADHD). It is important for researchers and clinicians to be aware of groups vulnerable to delayed or incomplete diagnosis. In this retrospective review of data from the CDC Survey of Pathways to Diagnostics and Services (SPDS) and the National Survey of the Diagnosis and Treatment of ADHD and Tourette Syndrome (DTAT), we sought to assess the impact of race, ethnicity, sex, poverty level, and diagnosing provider type on age of first concern and age of final diagnosis in children diagnosed with ASD, ADHD, and ASD+ADHD. We predicted that age of first concern and age of final diagnosis would vary by sex, race, poverty level, identifier of first symptoms, provider type, and comorbidities. Parents/guardians of 5,959 children aged 3-17 completed the surveys; in the current sample, 2,966 cases were from DTAT and 2,993 were from SPDS. We used a series of ANOVAs to assess differences in the variables of interest by group. Age of first concern was significantly impacted (p [less than] 0.05) by Race, Race x Poverty Level, and Race x Poverty Level x Sex for the ASD+ADHD group. Age of final diagnosis was not significantly impacted (p [greater than] 0.05) by Poverty Level, Race x Poverty Level, and Sex x Race x Poverty Level for the ASD group. Identifier of first symptoms significantly impacted (p [less than] 0.05) age of first concern for all groups, while identifier of first concerns only significantly impacted (p [less than] 0.05) the ASD and ADHD groups. Post-hoc analyses revealed specific patterns of risk. Specific combinations of demographic factors increase vulnerability for later diagnosis. These findings suggest that provider- and patient-centered education is needed to increase surveillance in at-risk populations.Item Demographic and Psychosocial Correlates of COVID-19 Vaccination Status among a Statewide Sample in Texas(MDPI, 2023-04-28) Luningham, Justin M.; Akpan, Idara N.; Taskin, Tanjila; Alkhatib, Sarah A.; Vishwanatha, Jamboor K.; Thompson, Erika L.The COVID-19 pandemic has been a global public health concern since early 2020 and has required local and state-level responses in the United States. There were several Food and Drug Administration (FDA) approved vaccines available for the prevention of COVID-19 as of August 2022, yet not all states have achieved high vaccination coverage. Texas is a particularly unique state with a history of opposing vaccination mandates, as well as a large and ethnically/racially diverse population. This study explored the demographic and psychosocial correlates of COVID-19 vaccinations among a statewide sample in Texas. A quota sample of 1089 individuals was surveyed online from June-July 2022. The primary outcome in this study was COVID-19 vaccination status (fully vaccinated, partially vaccinated, or unvaccinated) and included independent variables related to demographics, COVID-19 infection/vaccine attitudes and beliefs, and challenges related to the COVID-19 pandemic. Hispanic/Latinx individuals were more likely than non-Hispanic White individuals to be partially vaccinated as opposed to unvaccinated. Higher education levels and confidence that the FDA would ensure a safe COVID-19 vaccine were strongly associated with a higher likelihood of being fully vaccinated. In addition, some challenges brought on by the pandemic and concerns about becoming infected or infecting others were associated with a higher likelihood of being partially or fully vaccinated. These findings emphasize the need to further investigate the interaction between individual and contextual factors in improving COVID-19 vaccination rates, especially among vulnerable and disadvantaged populations.